ReviewFrontiers in pharmacology2024

β-blockers and statins: exploring the potential off-label applications in breast, colorectal, prostate, and lung cancers.

Pedro Gabriel Senger Braga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.